Evidence map›Paper›PMID 23137061›Full record

ArticleChemical research in toxicology2013

Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype.

Erik J Tokar, Rachel J Person, Yang Sun, Alan O Perantoni, Michael P Waalkes

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Risk assessment of small organoarsenic species in food.EFSA journal. European Food Safety Authority · 2024
    Article
  3. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  4. Article
  5. Toxicology reports · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Overexpression ofInternational journal of molecular sciences · 2020
    Article
  10. Article
  11. Review
  12. Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
  13. Article
  14. Article
  15. Cellular and Molecular Effects of Prolonged Low-Level Sodium Arsenite Exposure on Human Hepatic HepaRG Cells.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Erik J TokarNational Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences , Research Triangle Park, North Carolina 27709, United States.
Rachel J Person
Yang Sun
Alan O Perantoni
Michael P Waalkes
National Institute of Environmental Health Sciences · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · US

Funding

Stem Cell ToxicologyZIAES102925 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TOKAR, ERIK · 2010 to 2021
$25.3M
GrowthDifferentiation Factors in OrganogenesisZIABC005093 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PERANTONI, ALAN · 2009 to 2019
$11.0M
Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

Inorganic arsenic in the drinking water is a multisite human carcinogen that potentially targets the kidney. Recent evidence also indicates that developmental arsenic exposure impacts renal carcinogenesis in humans and mice. Emerging theory indicates that cancer may be a disease of stem cells (SCs) and that there are abundant active SCs during early life. Therefore, we hypothesized that inorganic arsenic targets SCs, or partially differentiated progenitor cells (PCs), for oncogenic transformation. Thus, a rat kidney SC/PC cell line, RIMM-18, was chronically exposed to low-level arsenite (500 nM) for up to 28 weeks. Multiple markers of acquired cancer phenotype were assessed biweekly during arsenic exposure, including secreted matrix metalloproteinase (MMP) activity, proliferation rate, colony formation in soft agar, and cellular invasiveness. Arsenic exposure by 10 weeks and after also induced marked and sustained increases in colony formation, indicative of the loss of contact inhibition, and increased invasiveness, both cancer cell characteristics. Compared to the passage-matched control, chronic arsenic exposure caused exposure-duration dependent increases in secreted MMP-2 and MMP-9 activity, Cox-2 expression, and more rapid proliferation (all >2-fold), characteristics typical of cancer cells. Dysregulation of SC maintenance genes and signaling pathways are common during oncogenesis. During arsenite exposure, expression of several genes associated with normal kidney development and SC regulation and differentiation (i.e., Wt-1, Wnt-4, Bmp-7, etc.) were aberrantly altered. Arsenic-exposed renal SCs produced more nonadherent spheroid bodies that grew much more aggressively in Matrigel, typical of cancer SCs (CSCs). The transformed cells also showed gene overexpression typical of renal SCs/CSCs (CD24, Osr1, Ncam) and arsenic adaptation such as overexpression of Mt-1, Mt2, Sod-1, and Abcc2. These data suggest that inorganic arsenic induced an acquired cancer phenotype in vitro in these rat kidney SCs potentially forming CSCs and, consistent with data in vivo, indicate that these multipotent SCs may be targets of arsenic during renal carcinogenesis.

Indexed as

AC133 AntigenAnimalsAntigens, CDArsenicATP-Binding Cassette, Sub-Family C ProteinsCD24 AntigenCell LineCell ProliferationCell Transformation, NeoplasticCyclooxygenase 2GlycoproteinsHumansKidneyKidney NeoplasmsMatrix Metalloproteinase 2Matrix Metalloproteinase 9ABCC2 protein, humanAC133 AntigenAntigens, CDArsenicATP-Binding Cassette, Sub-Family C ProteinsCD24 AntigenCyclooxygenase 2GlycoproteinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9MetallothioneinMultidrug Resistance-Associated Protein 2PeptidesSOD1 protein, humanSod1 protein, mouseSod1 protein, ratSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID23137061
PMCPMC3921970
OpenAlexW2075596346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.